title: Pediatric antiphospholipid syndrome.
abstract: Antiphospholipid syndrome (APS) is a multisystem autoimmune condition characterized by vascular thromboses associated with persistently positive antiphospholipid antibodies. There is currently a paucity of data (incidence, prevalence, thrombosis risk, and effective treatment) in pediatric APS. The purpose of this report is to review the current literature on APS in children and neonates, identify the gaps in current knowledge, and suggest avenues for studies to fill those gaps.
authors: Pediatric Rheumatology, Cohen Children's Medical Center-North Shore Long Island Jewish Medical Center, The Hofstra North Shore-LIJ School of Medicine, 1991 Marcus Avenue, Suite M100, Lake Success, NY, 11040, USA, caguiar@nshs.edu.
authors: Cassyanne L
authors: CL
authors: Aguiar
authors: Arzu
authors: A
authors: Soybilgic
authors: Tadej
authors: T
authors: Avcin
authors: Barry L
authors: BL
authors: Myones
mesh_terms: D000367:Age Factors; D016736:Antiphospholipid Syndrome / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D035843:Biomedical Research / Q000379:methods / Q000639:trends; D002648:Child; D006801:Humans; D007231:Infant, Newborn; D012307:Risk Factors